Prevalence and Disease Burden of Chronic Kidney Disease.

@article{Lv2019PrevalenceAD,
  title={Prevalence and Disease Burden of Chronic Kidney Disease.},
  author={Ji‐cheng Lv and Luxia Zhang},
  journal={Advances in experimental medicine and biology},
  year={2019},
  volume={1165},
  pages={
          3-15
        }
}
  • J. Lv, Luxia Zhang
  • Published 2019
  • Medicine, Biology
  • Advances in experimental medicine and biology
Chronic kidney disease (CKD) has been recognized as a leading public health problem worldwide. The global estimated prevalence of CKD is 13.4% (11.7-15.1%), and patients with end-stage kidney disease (ESKD) needing renal replacement therapy is estimated between 4.902 and 7.083 million. Through its effect on cardiovascular risk and ESKD, CKD directly affects the global burden of morbidity and mortality worldwide. The global increase in this disease is mainly driven by the increase in the… 
Chronic kidney disease and dialysis therapy: incidence and prevalence in the world
TLDR
Specific strategies and interventions should be urgently aimed at reducing in the burden of CKD by means of the prevention, detection and treatment of DM, AH, and early stages of CKd.
Emerging Biomarkers for Early Detection of Chronic Kidney Disease
TLDR
This review aims to provide comprehensive insight into diagnostic methods available for early detection of CKD and discusses the following topics: markers of glomerular injury; markers of tubulointerstitial injury; the role of omics; (iv) therole of microbiota; (v) and finally, the roles of microRNA in the early detectionof CKD.
Preventing CKD in Developed Countries
Editorial: Innovative Biologics and Drugs to Target Renal Inflammation
TLDR
The goal of this Research Topic was to highlight recent basic, pre-clinical, and clinical progress and opportunities related to the targeting of renal inflammation using drugs and biologic agents by publishing relevant full-length and short original research communications and review articles.
Disease severity and renal outcomes of patients with chronic kidney disease infected with COVID-19
TLDR
Despite comparable disease severity at presentation, patients with CKD had significantly more AKI events and required more renal replacement therapy during hospitalization than control patients did, and mortality increased as CKD stage increased.
Antisense Oligonucleotide: A Potential Therapeutic Intervention for Chronic Kidney Disease
TLDR
The ASOs developed for the identification of CKD-relevant genes and/or the simultaneous development of the ASOs as potential therapeutics towards treating CKD are reviewed.
An Update on Hepatocellular Carcinoma in Chronic Kidney Disease
TLDR
It appears that important predictors of HCC in dialysis population are hepatotropic viruses (HBV and HCV) and cirrhosis, and 1-, 3-, and 5-year survival rates are lower in HCC patients on long-term dialysis than those with HCC and intact kidneys.
Sepsis and the Risks of Long-Term Renal Adverse Outcomes in Patients With Chronic Kidney Disease
TLDR
It is found that patients with CKD discharged from hospitalization for sepsis have higher risks of subsequent renal adverse events than non-sepsis group.
Prevalence and Associated Factors of Kidney Dysfunction in Patients with Hypertension and/or Diabetes Mellitus from a Primary Care Population in Northwest China
TLDR
KD is common in patients with hypertension and/or DM in Northwest China and more attention should be paid to high-risk patients, especially to those with co-existence of hypertension and DM, which may further improve KD management in this patient population.
Uremic Toxins and Cardiovascular Risk in Chronic Kidney Disease: What Have We Learned Recently beyond the Past Findings?
TLDR
A better understanding of these toxins’ roles in the elevated prevalence of CVDs among CKD patients might facilitate the development of targeted treatments and the mechanisms that underlie the influence of dietary and gut-derived UTs onCVDs are reviewed.
...
...

References

SHOWING 1-10 OF 65 REFERENCES
Prevention of chronic kidney disease: a global challenge.
TLDR
Issues related to general population as well as targeted screening, favoring the latter are addressed, and the links between albuminuria, CKD, and cardiovascular disease (CVD) are highlighted as an increasing number of studies identifyalbuminuria/proteinuria, aswell as CKD as major markers of CVD.
K/DOQI clinical practice guidelines for chronic kidney disease
TLDR
This guideline contains brief reference to diagnosis and clinical interventions and can serve as a "road map" linking other clinical practice guidelines and pointing out where other guidelines need to be developed.
Global Prevalence of Chronic Kidney Disease – A Systematic Review and Meta-Analysis
TLDR
CKD has a high global prevalence with a consistent estimated global CKD prevalence of between 11 to 13% with the majority stage 3, and future research should evaluate intervention strategies deliverable at scale to delay the progression of CKD and improve CVD outcomes.
Cardiovascular disease in chronic kidney disease. A clinical update from Kidney Disease: Improving Global Outcomes (KDIGO).
TLDR
The current state of knowledge and the implications for patient care in important topic areas, including coronary artery disease and myocardial infarction, congestive heart failure, cerebrovascular disease, atrial fibrillation, peripheral arterial disease, and sudden cardiac death are defined.
The global burden of chronic kidney disease: estimates, variability and pitfalls
TLDR
The strategies discussed include approaches to improve testing methodologies for more accurate assessment of GFR, to improve awareness of factors that can alter GFR readouts, and to more accurately stage CKD in certain populations, including the elderly.
Chinese cohort study of chronic kidney disease: design and methods
TLDR
The C‐STRIDE would provide important evidence for underlying mechanisms of CKD progression, valuable information for clinical guidelines and healthcare policies in China, and candidate markers and predicted models will be established.
The Prevalence of Nontraditional Risk Factors for Coronary Heart Disease in Patients with Chronic Kidney Disease
TLDR
This observational study hypothesized that risk factors for cardiovascular disease are increased in patients who have chronic kidney disease before developing kidney failure, and compared levels of these factors by level of estimated GFR in a large U.S. representative sample.
...
...